Darapladib
Darapladib (S7520-GRP)
Products
Description
Darapladib is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.25 nM. Phase 3.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S7520 |
| Target | Phospholipase (e.g. PLA) |